Please assess the completion status of the following clinical trial:

Trial Title: Sexual Functioning After Primary Treatment of Ovarian Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months~* Women must have no clinical evidence of disease~* At least 18 years of age~* English speaking~* Able to participate in the informed consent process~* Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC.~Exclusion Criteria:~* Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment~* Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination~* Women with borderline (low malignant potential) ovarian cancers~* Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic~* Women with a history of prior whole pelvic radiation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): FSFI score \<= 26
- 2 (Type: None): FSFI score \>26

Based on this trial design, predict the completion outcome and termination type (if applicable).